| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |